Overview

Full Product Details

Author:   Chadi Nabhan
Publisher:   Nova Science Publishers Inc
Imprint:   Nova Science Publishers Inc
Weight:   0.688kg
ISBN:  

9781600215261

ISBN 10:   1600215262
Pages:   226
Publication Date:   27 September 2007
Audience:   Professional and scholarly ,  College/higher education ,  Professional & Vocational ,  Postgraduate, Research & Scholarly
Format:   Hardback
Publisher's Status:   Active
Availability:   Available To Order  
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Risk Stratification in the Management of Chronic Lymphocytic Leukaemia (CLL); New Research in Chronic Lymphocytic Leukaemia; Transplantation Strategies for the Treatment of Chronic Lymphocytic Leukaemia; What is the Clinical and Biological Significance of the BCL-2 Family n Apoptosis Regulation in B-Cell Chronic Lymphocytic Leukaemia (CLL)?; Mode of Action of Rituximab in Chronic Lymphocytic Leukaemia; Activation of Tis11b, an Inducer of MRNA Instability and Induction of Apoptosis; Genetic Factors Impacting the Biology of B Cell Chronic Lymphocytic Leukaemia (B-CLL); The ""In Vitro Apoptosis"" Profile in CLL Correlates with some Prognostic Markers, Treatment History and In Vivo Response to Treatment; CD38 Expression in B-Cell Chronic Lymphocytic Leukaemia: What have we learned?; Novel and Uncommon Chromosome Aberrations in Chronic-Lymphocytic Leukaemia: Cytogenetic, FISH and Clinical Evaluation; Index.

Reviews

Author Information

Tab Content 6

Author Website:  

Countries Available

All regions